Comments
Loading...
Repligen Stock Guidance | NASDAQ:RGEN | Benzinga
Repligen issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/20/2025 | RGEN | Repligen | FY | 2025 | $1.67 | $1.76 | $1.71 | $685.00M | $710.00M | $692.76M | Get Alert |
| 11/12/2024 | RGEN | Repligen | FY | 2024 | $1.50 | $1.58 | $1.43 | $630.00M | $639.00M | — | Get Alert |
| 09/18/2024 | RGEN | Repligen | FY | 2024 | — | — | — | $627.00M | $642.00M | $626.65M | Get Alert |
| 07/30/2024 | RGEN | Repligen | FY | 2024 | $1.42 | $1.49 | $1.45 | $620.00M | $635.00M | $636.56M | Get Alert |
| 05/01/2024 | RGEN | Repligen | FY | 2024 | $1.42 | $1.49 | $1.46 | $620.00M | $650.00M | $635.64M | Get Alert |
| 02/21/2024 | RGEN | Repligen | FY | 2024 | $1.42 | $1.49 | $1.77 | $620.00M | $650.00M | $660.71M | Get Alert |
| 10/31/2023 | RGEN | Repligen | FY | 2023 | $1.70 | $1.76 | $1.74 | $635.00M | $645.00M | $645.78M | Get Alert |
| 08/02/2023 | RGEN | Repligen | FY | 2023 | $1.72 | $1.80 | $2.29 | $635.00M | $665.00M | $721.07M | Get Alert |
| 05/02/2023 | RGEN | Repligen | FY | 2023 | $2.35 | $2.42 | $2.64 | $720.00M | $760.00M | $779.98M | Get Alert |
| 02/22/2023 | RGEN | Repligen | FY | 2023 | $2.61 | $2.69 | $2.92 | $760.00M | $800.00M | $800.22M | Get Alert |
| 11/01/2022 | RGEN | Repligen | FY | 2022 | $3.15 | $3.20 | $3.20 | $795.00M | $805.00M | $803.99M | Get Alert |
| 08/02/2022 | RGEN | Repligen | FY | 2022 | $3.13 | $3.20 | $3.09 | $790.00M | $810.00M | $788.55M | Get Alert |
| 04/27/2022 | RGEN | Repligen | FY | 2022 | $3.07 | $3.15 | $3.25 | $770.00M | $800.00M | $819.47M | Get Alert |
| 02/17/2022 | RGEN | Repligen | FY | 2022 | $3.21 | $3.30 | $3.15 | $800.00M | $830.00M | $801.46M | Get Alert |
| 10/28/2021 | RGEN | Repligen | FY | 2021 | $2.86 | $2.91 | $2.68 | $655.00M | $665.00M | $640.61M | Get Alert |
| 07/27/2021 | RGEN | Repligen | FY | 2021 | $2.71 | $2.78 | $2.25 | $625.00M | $645.00M | $585.90M | Get Alert |
| 05/04/2021 | RGEN | Repligen | FY | 2021 | $2.21 | $2.28 | $1.91 | $565.00M | $590.00M | $513.38M | Get Alert |
| 02/24/2021 | RGEN | Repligen | FY | 2021 | $1.86 | $1.94 | $1.65 | $500.00M | $525.00M | $459.53M | Get Alert |
| 11/05/2020 | RGEN | Repligen | FY | 2020 | $1.41 | $1.45 | $1.28 | $348.00M | $352.00M | $337.53M | Get Alert |
| 07/30/2020 | RGEN | Repligen | FY | 2020 | $1.24 | $1.29 | $1.13 | $332.00M | $340.00M | $317.04M | Get Alert |
FAQ
What is the most recent guidance for Repligen (RGEN)?
The most recent guidance for Repligen (RGEN) was reported on February 20, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $1.67 to $1.76, compared to the estimated EPS of $1.71. Additionally, Repligen forecasted revenue between $0.69B and $0.71B for the quarter.
Browse guidance and forecast on all stocks.